Ameliorating effects of ethanol extract of fructus mume on scopolamine-induced memory impairment in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Kim, Min Soo ^a   Jeon, Won Kyung ^b   Lee, Kye Wan ^c   Park, Yu Hwa ^c   Han, Jung Soo ^a  

^a Konkuk University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c Dongkook Pharm Co Ltd R and D Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALCOHOL; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; FRUCTUS MUME EXTRACT; NEUROPROTECTIVE AGENT; PLANT EXTRACT; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CHOLINERGIC NERVE CELL; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUCTUS MUME; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; MEDICINAL PLANT; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL MEMORY;

EID: 84923902520     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/102734     Document Type: Article

References (35)

1. L. Liu, S. Yuan, Y. Sun et al., "The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6- trinitrobenzene sulfonic acid in rats," Journal of Ethnopharmacology, vol. 126, no. 3, pp. 557-564, 2009.
2. H.-J. Choi, O.-H. Kang, P.-S. Park et al., "Mume Fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide- stimulated macrophages," Journal of Medicinal Food, vol. 10, no. 3, pp. 460-466, 2007.
3. W. K. Jeon, J. Ma, B.-R. Choi et al., "Effects of Fructus mume extract on MAPK and NF-0B signaling and the resultant improvement in the cognitive deficits induced by chronic cerebral hypoperfusion," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 450838, 13 pages, 2012.
4. H. Tomimoto, M. Ihara, H. Wakita et al., "Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat," Acta Neuropathologica, vol. 106, no. 6, pp. 527-534, 2003.
5. M. Tsuchiya, K. Sako, S. Yura, and Y. Yonemasu, "Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats," Experimental Brain Research, vol. 89, no. 1, pp. 87-92, 1992.
6. H. Wakita, H. Tomimoto, I. Akiguchi, and J. Kimura, "Dosedependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia," Brain Research, vol. 792, no. 1, pp. 105-113, 1998.
7. D. Kumaran,M. Udayabanu,M. Kumar, R. Aneja, and A. Katyal, "Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats," Neuroscience, vol. 155, no. 3, pp. 626-639, 2008.
8. J.-W. Ni, K. Matsumoto, H.-B. Li, Y. Murakami, and H. Watanabe, "Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat," Brain Research, vol. 673, no. 2, pp. 290-296, 1995.
9. B.-R. Choi, K. J. Kwon, S. H. Park et al., "Alternations of septalhippocampal system in the adult wistar rat with spatial memory impairments induced by chronic cerebral hypoperfusion," Experimental Neurobiology, vol. 20, no. 2, pp. 92-99, 2011.
10. M. G. Baxter and A. A. Chiba, "Cognitive functions of the basal forebrain," Current Opinion in Neurobiology, vol. 9, no. 2, pp. 178-183, 1999.
11. M. Gallagher and P. J. Colombo, "Ageing: the cholinergic hypothesis of cognitive decline," Current Opinion in Neurobiology, vol. 5, no. 2, pp. 161-168, 1995.
12. D. S. Olton, "Dementia: animal models of the cognitive impairments following damage to the basal forebrain cholinergic system," Brain Research Bulletin, vol. 25, no. 3, pp. 499-502, 1990.
13. A. A. Chiba, P. J. Bushnell, W. M. Oshiro, and M. Gallagher, "Selective removal of cholinergic neurons in the basal forebrain alters cued target detection," NeuroReport, vol. 10, no. 14, pp. 3119-3123, 1999.
14. R. T. Bartus, R. L. Dean III, B. Beer, and A. S. Lippa, "The cholinergic hypothesis of geriatric memory dysfunction," Science, vol. 217, no. 4558, pp. 408-417, 1982.
15. E. Giacobini, "Cholinesterase inhibitors: new roles and therapeutic alternatives," Pharmacological Research, vol. 50, no. 4, pp. 433-440, 2004.
16. Y. Oda, "Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system," Pathology International, vol. 49, no. 11, pp. 921-937, 1999.
17. G. R. Dawson, C.M. Heyes, and S.D. Iversen, "Pharmacological mechanisms and animal models of cognition," Behavioural Pharmacology, vol. 3, no. 4, pp. 285-297, 1992.
18. S.D. Iversen, "Behavioural evaluation of cholinergic drugs," Life Sciences, vol. 60, no. 13-14, pp. 1145-1152, 1997.
19. S. E. Molchan, R. A. Martinez, J. L. Hill et al., "Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model," Brain Research Reviews, vol. 17, no. 3, pp. 215-226, 1992.
20. H. Eichenbaum, T. Otto, and N. J. Cohen, "The hippocampus- what does it do?" Behavioral and Neural Biology, vol. 57, no. 1, pp. 2-36, 1992.
21. L. R. Squire and S. M. Zola, "Structure and function of declarative and nondeclarative memory systems," Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 13515-13522, 1996.
22. E. Abe, "Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain," Psychopharmacology, vol. 105, no. 3, pp. 310-316, 1991.
23. S. Lee, J. Kim, S. G. Seo, B.-R. Choi, J.-S. Han, and K. W. Lee, "Sulforaphane alleviates scopolamine-inducedmemory impairment in mice," Pharmacological Research, vol. 85, pp. 23-32, 2014.
24. E. J. Shin, H. J. Hur, M. J. Sung et al., "Ethanol extract of the Prunus mume fruits stimulates glucose uptake by regulating PPAR-γ in C2C12 myotubes and ameliorates glucose intolerance and fat accumulation in mice fed a high-fat diet," Food Chemistry, vol. 141, no. 4, pp. 4115-4121, 2013.
25. Q. Jin, C. Lee, J. W. Lee, I. S. Lee, M. K. Lee, and W. K. Jeon, "Chemical constituents from the fruits of Prunus mume," Natural Product Sciences, vol. 18, no. 3, pp. 200-203, 2012.
26. M. Gallagher, R. Burwell, and M. Burchinal, "Severity of spatial learning impairment in aging: development of a learning index for performance in the morris water maze," Behavioral Neuroscience, vol. 107, no. 4, pp. 618-626, 1993.
27. M. D. Lindner, J. B. Hogan, D. B. Hodges Jr. et al., "Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, withmoderate effects on simple conditioning and attention, and small effects on working memory and spatialmapping," Psychopharmacology (Berl), vol. 188, no. 4, pp. 629-640, 2006.
28. V. P. Prasher, "Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population," International Journal of Geriatric Psychiatry, vol. 19, no. 6, pp. 509-515, 2004.
29. X.-T. Yan, S.-H. Lee,W. Li et al., "Evaluation of the antioxidant and anti-osteoporosis activities of chemical constituents of the fruits of Prunus mume," Food Chemistry, vol. 156, pp. 408-415, 2014.
30. H. A. Kwon, Y.-J. Kwon, D.-Y. Kwon, and J. H. Lee, "Evaluation of antibacterial effects of a combination of Coptidis Rhizoma, Mume Fructus, and Schizandrae Fructus against Salmonella," International Journal of Food Microbiology, vol. 127, no. 1-2, pp. 180-183, 2008.
31. M. G. Giovannini, G. Spignoli, V. Carla, and G. Pepeu, "A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine," Pharmacological Research, vol. 24,no. 4, pp. 395-405, 1991.
32. S. Hirokawa, M. Nose, A. Ishige, S. Amagaya, T. Oyama, and Y. Ogihara, "Effect of Hachimi-jio-gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain," Journal of Ethnopharmacology, vol. 50, no. 2, pp. 77-84, 1996.
33. Z. Dong and A. Fu, "Prevention of age-relatedmemory deficit in transgenic mice by human choline acetyltransferase," European Journal of Pharmacology, vol. 683, no. 1-3, pp. 174-178, 2012.
34. A. L. Fu, S. J. Huang, and M. J. Sun, "Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase," Biochemical and Biophysical Research Communications, vol. 336, no. 1, pp. 268-273, 2005.
35. L. Huang, T. Su, and X. Li, "Natural products as sources of new lead compounds for the treatment of Alzheimer's disease," Current Topics in Medicinal Chemistry, vol. 13, no. 15, pp. 1864-1878, 2013.